OSR Health (OSRHW) Retained Earnings (2021 - 2026)
OSR Health (OSRHW) posted Retained Earnings of -$1.7 million for Q1 2026, up 95.53% sequentially from -$37.2 million in Q4 2025, and up 94.57% YoY from -$853600.5 in Q1 2025.
OSR Health (OSRHW) Retained Earnings (2021 - 2026) Analysis & Trends
OSR Health has reported Retained Earnings for 6 years, with the latest figure at -$1.7 million in Q1 2026.
- Quarterly Retained Earnings rose 94.57% year-over-year to -$1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 million (up 94.57% YoY) and the FY2025 annual result came in at -$37.2 million, down 93.87% from the prior year.
- Retained Earnings advanced to -$1.7 million in Q1 2026 per OSRHW's latest filing, from -$37.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at $4.7 million in Q3 2025 and troughed at -$37.2 million in Q4 2025.
- A 5-year average of -$10.7 million and a median of -$3.2 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2026: Retained Earnings plunged 6150.41% in 2023, then soared 94.57% in 2026.
- Over 5 years, Retained Earnings stood at -$62508.0 in 2022, then slumped by 6150.41% to -$3.9 million in 2023, then sank by 390.74% to -$19.2 million in 2024, then tumbled by 93.87% to -$37.2 million in 2025, then surged by 95.53% to -$1.7 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$1.7 million, -$37.2 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 4.38 Bn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 6.57 Bn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | -40.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.66 Mn |
| Dec 31, 2025 | -37.17 Mn |
| Sep 30, 2025 | 4.72 Mn |
| Jun 30, 2025 | -30.18 Mn |
| Mar 31, 2025 | -30.57 Mn |
| Dec 31, 2024 | -19.17 Mn |
| Mar 31, 2024 | -4.31 Mn |
| Dec 31, 2023 | -3.91 Mn |
| Sep 30, 2023 | -2.46 Mn |
| Jun 30, 2023 | -2.09 Mn |
| Mar 31, 2023 | -1.83 Mn |
| Dec 31, 2022 | -62,508.00 |
| Dec 31, 2021 | -27,120.00 |